Articles from BIOTECH Patent News (December 1, 1999)

1-53 out of 53 article(s)

Title	Type	Words
Abgenix to become sole owner of XenoMouse fully human antibody technology.	Brief Article	723
Affymetrix and Orchid announce alliance to develop and commercialize new GeneChip genotyping assays.	Brief Article	591
Aquasearch awarded another patent for microalgae production technology.	Brief Article	469
Associated Pathologists Laboratories awarded second United States patent.	Brief Article	224
Biosite signs collaboration and phage display licensing agreement with MorphoSys.	Brief Article	484
Boehringer Mannheim obtains United States patent.	Brief Article	26
Brigham & Women's Hospital applies for patent.	Brief Article	40
Cadus applies for patent.	Brief Article	31
Cambridge NeuroScience receives two United States patents and three United States patent allowances.	Brief Article	260
Chiron settles infringement suit against Gilead.	Brief Article	337
Connaught obtains United States patent.	Brief Article	41
Corixa obtains United States patent.		57
Creative Biomolecules applies for patent.	Brief Article	26
Demegen awarded United States patent for stabilized peptides and method for treating cancers and other diseases.	Brief Article	395
Dow AgroSciences files cotton patent litigation suit against Monsanto.	Brief Article	281
Energy Biosystems obtains United States patent.		51
Gene Logic discovers genes for renal disease.	Brief Article	429
Genetics Institute applies for patent.	Brief Article	35
GenVec applies for patent.	Brief Article	41
Human Genome Sciences announces exercise of option.	Brief Article	322
Human Genome Sciences applies for patent.		39
ILEX Oncology and Millennium submit biologics license application for CAMPATH.	Brief Article	324
Indiana University obtains United States patent.		38
Inex applies for patent.	Brief Article	34
Institut Francais du Petrole obtains United States patent.		61
Institut Pasteur obtains United States patent.		43
Isis obtains United States patent.	Brief Article	46
Life Technologies releases novel universal cloning technology and its adoption by key programs providing clones.	Brief Article	1269
Ludwig Institute obtains United States patent.		45
Millennium announces the completion of LeukoSite and Millennium BioTherapeutics mergers.	Brief Article	351
Millennium delivers validated target in prostate cancer for screening to Eli Lilly.	Brief Article	463
MTA Szegedi Biologiai Kozpontja obtains United States patent.		66
Nemours Foundation obtains United States patent.	Brief Article	56
Neuro-Biotech obtains United States patent.	Brief Article	38
Novo Nordisk obtains United States patent.		26
Osaka Bioscience Institute applies for patent.	Brief Article	27
Pioneer Hi-Bred obtains United States patent.		63
Quidel exclusive licensee for patent granted for peptide used in managing osteoporosis.	Brief Article	386
Regeneron applies for patent.	Brief Article	35
Royal Veterinary obtains United States patent.	Brief Article	44
Sabinsa granted third patent on Bioperine bioavailability enhancing phytonutrient.	Brief Article	412
SafeScience announces issuance of patent for Elexa fungal infection inhibitor.	Statistical Data Included	1274
Scripps Research Institute obtains United States patent.	Brief Article	49
Thomas Jefferson University applies for patent.	Brief Article	34
Thomas Jefferson University obtains United States patent.	Brief Article	47
Transgene obtains United States patent.	Brief Article	35
University of Alabama at Birmingham applies for patent.	Brief Article	36
University of Maryland obtains United States patent.	Brief Article	33
University of Texas applies for patent.	Brief Article	40
University of Toronto applies for patent.		43
Ventana sues Cytologix for patent infringement.	Brief Article	192
Yissum applies for patent.	Brief Article	47
Zymogenetics applies for patent.	Brief Article	27